Healthy volunteers needed to test two forms of heart failure medicine
NCT ID NCT07476157
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study will test two versions of a drug (AD-118 and AD-1181) in 70 healthy adults to see how they are processed by the body and if they are safe. Participants will receive a single dose of each version under fasting conditions. The study does not aim to treat any disease, but to gather important information for future heart failure research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
H PLUS YANGJI HOSPITAL, Seoul
Seoul, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a diabetes drug tame chronic heart failure? a Real-World study investigates
- Heart rehab goes hybrid: can a mix of home and clinic sessions boost adherence?
- Healthy volunteers test two versions of a promising heart failure drug
- Could a heart pill boost exercise capacity in chronic heart failure?
- Nurse coaching may help heart failure patients avoid hospital visits by mastering fluid control
- Sweat-Powered relief: could a High-Tech suit drain fluid from heart failure patients?